NLRP3:CD3 ratio, CD3+C5AR1+, CD3+CLEC4A+ and CD3+NLRP3+ MFI were significantly higher in early-stage NSCLC compared to healthy volunteers with an area under the ROC curve of 0.69–0.76. This evidence concerns the gene CLEC4A and non-small cell lung carcinoma.